|
Clinical study on effect of xianlong capsule in treating senile vascular dementia |
|
View Full Text View/Add Comment Download reader |
|
KeyWord: |
Author Name | Affiliation | E-mail | Yan Zhao | Department of Senile Diseases, Xiyuan Hospital, China Academy of TCM, 100091, Beijing | quhh@amms. ac. cn | Wen-quan Zhou | Department of Senile Diseases, Xiyuan Hospital, China Academy of TCM, 100091, Beijing | | Pu Gao | Department of Senile Diseases, Xiyuan Hospital, China Academy of TCM, 100091, Beijing | | Ling Cui | Department of Senile Diseases, Xiyuan Hospital, China Academy of TCM, 100091, Beijing | |
|
Hits: 1020 |
Download times: 545 |
Abstract: |
Objective To assess the efficacy of Xianlong Capsule (XLC) in treating senile vascular dementia (VD). Methods Forty-six patients of VD were randomly divided into two groups. The patients in XLC group (n=24) were treated with XLC and the patients in the control group (n=22) were treated with Hydergine. The therapeutic effect on dementia, TCM Syndrome, neurofunction deficit score, activities of daily living (ADL) score, Hasegawa Dementia Score (HDS) and mini-mental state examination (MMSE), etc. were examined and compared before and after treatment. Results XLC could markedly increase MMSE scores and HDS of VD patients. It showed effect in ameliorating the TCM Syndromes and neurofunction deficit score significantly and could markedly improve the daily living activity of patients. The effect of XLC was better than that of Hydergine Conclusion XLC has definite effect in treating senile vascular dementia. |
Close |
|
|
|